Trial · NCT01199068
Adverse events590
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 590
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Paronychia | Infections and infestations | CS-7017 0.25 mg BID; Initial Portion | 1 | 3 | |
| other | Paronychia | Infections and infestations | CS-7017 0.50 mg BID; Initial Portion | 0 | 3 | |
| other | Paronychia | Infections and infestations | CS-7017 0.50 mg BID; Additional Portion | 1 | 8 | |
| other | Paronychia | Infections and infestations | CS-7017 0.50 mg BID; Initial + Additional Portions | 1 | 11 | |
| other | Paronychia | Infections and infestations | Overall | 2 | 14 | |
| other | Pneumonia | Infections and infestations | CS-7017 0.25 mg BID; Initial Portion | 0 | 3 | |
| other | Pneumonia | Infections and infestations | CS-7017 0.50 mg BID; Initial Portion | 1 | 3 | |
| other | Pneumonia | Infections and infestations | CS-7017 0.50 mg BID; Additional Portion | 1 | 8 | |
| other | Pneumonia | Infections and infestations | CS-7017 0.50 mg BID; Initial + Additional Portions | 2 | 11 | |
| other | Pneumonia | Infections and infestations | Overall | 2 | 14 | |
| other | Metastases to abdominal cavity | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | CS-7017 0.25 mg BID; Initial Portion | 1 | 3 | |
| other | Metastases to abdominal cavity | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | CS-7017 0.50 mg BID; Initial Portion | 0 | 3 | |
| other | Metastases to abdominal cavity | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | CS-7017 0.50 mg BID; Additional Portion | 0 | 8 | |
| other | Metastases to abdominal cavity | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | CS-7017 0.50 mg BID; Initial + Additional Portions | 0 | 11 | |
| other | Metastases to abdominal cavity | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Overall | 1 | 14 | |
| other | Metastatic pain | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | CS-7017 0.25 mg BID; Initial Portion | 0 | 3 | |
| other | Metastatic pain | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | CS-7017 0.50 mg BID; Initial Portion | 1 | 3 | |
| other | Metastatic pain | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | CS-7017 0.50 mg BID; Additional Portion | 0 | 8 | |
| other | Metastatic pain | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | CS-7017 0.50 mg BID; Initial + Additional Portions | 1 | 11 | |
| other | Metastatic pain | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Overall | 1 | 14 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01199068/events